article Open AccessTop 1% cited
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Annals of the Rheumatic Diseases · 2013 · Vol. 73(7) · pp. 1340–1349
Gerry Coghlan✉(The Royal Free Hospital)Christopher P. Denton(The Royal Free Hospital)Ekkehard Grünig(Heidelberg University)Diana Bonderman(Medical University of Vienna)Oliver Distler(University Hospital of Zurich)Dinesh Khanna(University of Michigan–Ann Arbor)Ulf Müller‐Ladner(University of Giessen)Janet Pope(Western University)Madelon C Vonk(Radboud University Nijmegen)Martin Doelberg(Actelion (Switzerland))Harbajan Chadha‐Boreham(Actelion (Switzerland))Harald Heinzl(Medical University of Vienna)D Rosenberg(Actelion (Switzerland))Vallerie V. McLaughlin(University of Michigan–Ann Arbor)James R. Seibold(Scleroderma Foundation)
Abstract
The novel, evidence-based DETECT algorithm for PAH detection in SSc is a sensitive, non-invasive tool which minimises missed diagnoses, identifies milder disease and addresses resource usage.
Pulmonary Hypertension Research and TreatmentsSystemic Sclerosis and Related DiseasesVenous Thromboembolism Diagnosis and ManagementMedicinePulmonary hypertensionReferralInternal medicineCardiologyNomogramMedical diagnosisRadiology
MeSH terms
AdultAgedAlgorithmsBreath TestsCross-Sectional StudiesEchocardiographyFemaleCardiac CatheterizationHumansHypertension, PulmonaryMaleMiddle AgedPulmonary Diffusing CapacityPulmonary Wedge PressureScleroderma, Systemic
Funding
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Teva Pharmaceutical Industries
- Celgene
- FibroGen
- United Therapeutics Corporation
- University of Michigan
- Albert-Ludwigs-Universität Freiburg
- Medac
- Genentech
- Division of Materials Research
- Actelion Pharmaceuticals
Citations
806
FWCI
41.94
field-weighted impact
References
41
Percentile
100%
vs. same field & year
Citations per year
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Respiratory Journal · 2015 · 3,147 citations
Definitions and Diagnosis of Pulmonary Hypertension
Journal of the American College of Cardiology · 2013 · 1,747 citations
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Respiratory Journal · 2022 · 1,919 citations
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal · 2022 · 3,372 citations
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal · 2015 · 6,926 citations
References
Principles and Practice of Screening for Disease.
Annals of Internal Medicine · 1968 · 3,078 citations
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Arthritis & Rheumatism · 1980 · 4,927 citations
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
Journal of the American College of Cardiology · 2009 · 2,349 citations
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
Annals of the Rheumatic Diseases · 2003 · 760 citations
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
European Heart Journal · 2009 · 3,846 citations
Changes in causes of death in systemic sclerosis, 1972–2002
Annals of the Rheumatic Diseases · 2007 · 1,505 citations
Pulmonary Arterial Hypertension
CHEST Journal · 2009 · 1,168 citations
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Annals of the Rheumatic Diseases · 2010 · 1,395 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.